Acadia Pharmaceuticals | ACAD - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
ALKERMES USD 142.86M 40.5M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Cara Therapeutics USD 4.62M 1.4M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Cytokinetics USD 24.71M 80.91M 2026-03
Eisai JPY 87.53B 11.64B 2026-06
Eli Lilly USD 5.03B 350M 2026-03
Incyte USD 1.39B 1.16B 2026-06
J&J USD 9.22B 1.24B 2026-06
Moderna USD 167M 6M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pfizer USD 4.58B 75M 2026-06
Prothena USD 4.3M 1.58M 2026-03
PTC Therapeutics USD 40.45M 14.96M 2026-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.61B 135M 2026-06